A web server for predicting inhibitors against bacterial target GlmU protein
© Singla et al; licensee BioMed Central Ltd. 2011
Received: 13 July 2010
Accepted: 6 July 2011
Published: 6 July 2011
The emergence of drug resistant tuberculosis poses a serious concern globally and researchers are in rigorous search for new drugs to fight against these dreadful bacteria. Recently, the bacterial GlmU protein, involved in peptidoglycan, lipopolysaccharide and techoic acid synthesis, has been identified as an important drug target. A unique C-terminal disordered tail, essential for survival and the absence of gene in host makes GlmU a suitable target for inhibitor design.
This study describes the models developed for predicting inhibitory activity (IC 50 ) of chemical compounds against GlmU protein using QSAR and docking techniques. These models were trained on 84 diverse compounds (GlmU inhibitors) taken from PubChem BioAssay (AID 1376). These inhibitors were docked in the active site of the C-terminal domain of GlmU protein (2OI6) using the AutoDock. A QSAR model was developed using docking energies as descriptors and achieved maximum correlation of 0.35/0.12 (r/r2) between actual and predicted pIC 50 . Secondly, QSAR models were developed using molecular descriptors calculated using various software packages and achieved maximum correlation of 0.77/0.60 (r/r2). Finally, hybrid models were developed using various types of descriptors and achieved high correlation of 0.83/0.70 (r/r2) between predicted and actual pIC 50 . It was observed that some molecular descriptors used in this study had high correlation with pIC 50 . We screened chemical libraries using models developed in this study and predicted 40 potential GlmU inhibitors. These inhibitors could be used to develop drugs against Mycobacterium tuberculosis.
These results demonstrate that docking energies can be used as descriptors for developing QSAR models. The current work suggests that docking energies based descriptors could be used along with commonly used molecular descriptors for predicting inhibitory activity (IC 50 ) of molecules against GlmU. Based on this study an open source platform, http://crdd.osdd.net/raghava/gdoq, has been developed for predicting inhibitors GlmU.
Antibiotic resistance has become a major hurdle to overcome bacterial diseases and thus there is always a need to find new drug targets or inhibitors or both. At present very few drugs are available in the market for treatment of M. tuberculosis infection as evolution of drug-resistant strains have resulted in little efficacy and some of them have shown undesired side-effects in host . Studies suggest that the prevalence of Multi Drug Resistant tuberculosis (MDR-TB) ranged from 6.7% for three drugs to 34% for four drugs and has caused an annual loss of around $4 - $5 billion [2–5]. Keeping in mind the rapidly changing pathogenesis of this lethal micro-organism, identification of novel inhibitors for recently discovered targets has become pressing need of the hour. GlmU is one such target which is essential for the survival of the pathogen [6, 7]. Recent studies on the Mycobacterial proteome using in-silico analysis suggested GlmU to be a potential drug target . This protein is a bi-functional enzyme that catalyzes a two steps reaction. Initially, catalytic conversion of glucosamine-1-phosphate to N-acetyl-glucosamine-1-phosphate takes place at the C-terminal domain followed by conversion of N-acetyl-glucosamine-1-phosphate to UDP-GluNAc at the N-terminal domain [9, 10]. Though the second step is present in prokaryotes as well as in humans, the first step is present only in prokaryotes . The absence of the first step in human makes it suitable for designing non-toxic inhibitors. The three dimensional structure of the GlmU enzyme has been reported from Escherichia coli, Mycobacterium tuberculosis, Streptococcus pneumoniae, Haemophilus influenzae, Yersinia pestis in apo and holo-forms [11–14]. These structures have missing coordinates for the C-terminal intrinsically disordered regions.
The identification of inhibitors using experimental techniques is an expensive and tedious job. Thus, there is need to develop theoretical models for predicting inhibitors against a potential target. In the past, a number of models has been developed using QSAR and docking [12–17] for the identification of novel inhibitors against different bacterial targets. Except KiDoQ  and CDD  none of them is freely available to the scientific community. KiDoQ is based on prediction of binding affinity against Dihydrodipicolinate synthase (DHDPS) enzyme of E.coli while CDD is a collection of compounds and predictive models against M.tb. It is important that newly developed models for predicting inhibitors should be made available in the public domain, in order to assist researchers in discovering new drugs against diseases of the poor. In this study, a systematic attempt has been made to address these issues. Firstly, we developed QSAR models using docking energies as molecular descriptors. Secondly, QSAR models were developed using commonly used molecular descriptors calculated using various freeware and commercial software packages. Thirdly, hybrid models were developed using docking energy based descriptors and commonly used molecular descriptors. Finally, a web server has been implemented using the best models developed in this study, hence providing an open source platform to the scientific community for discovering new drugs against bacterial target GlmU protein.
We retrieved 125 GlmU inhibitors from PubChem Bioassay AID-1376 [20, 21] with known IC 50 values against M.tuberculosis GlmU. These inhibitors exhibit a wide range of activity (1-9999 μM) and structural diversity (see clustering at 70% in Additional file-1). There were errors in calculating descriptors for 4 molecules and hence a reduced set of 119 molecules was considered for further analysis. After docking these 119 molecules in active site of GlmU protein, 27 molecules have higher energy than substrate. After removing these molecules, we were left with only 92 molecules which were further studied. At the time of QSAR model development, we observed that around 8 molecules acted as outliers. These molecules were also removed which led us to a final dataset of 84 molecules to be used in this study.
In this approach, we performed blind docking against GlmU protein of M. tuberculosis using AutoDock . Ideally molecules should be docked against the GlmUmtb, but the coordinates available in the Protein Databank (PDB) for full length (residue 1-479) GlmUmtb are unliganded and show a disordered loop (N397 to R405) in the active site. For these reasons, we developed a structural model of GlmUmtb protein using Modeller 9v8 based on 3D8V as the basic template . For the missing loop region in 3D8V, GlmUecoli in liganded form (2OI6) was used as template. This was followed by loop refinement and the model with best DOPE score was selected for further studies. We generated a trimeric state of the modeled structure using Matchmaker utility of chimera  with 2OI6 as the template for superposition.
Site Specific Docking
In this approach, potential inhibitors were docked in the substrate binding site of GlmUecoli. We obtained the structure of GlmU protein of E. coli (2OI6) complex with substrates from the PDB. Since we were focusing on the glucosamine-1-phosphate binding pocket, that requires only 2-chain association, dimeric model was used as input for docking studies after removal of hetero atoms. An automated flexible docking approach was carried out to find effective molecule with specific binding using AutoDock.
Receptor and ligand preparation
Protein and ligand preparation was performed using the AutoDock and involved the addition of hydrogen atoms, computing charges, merging non-polar hydrogen atoms and defining AD4 atom types to ensure that atom conformed to the AutoDock atom types. A grid was defined using Autogrid feature of the software and docking conformation search was done using a genetic algorithm (GA) procedure with t-step value of 1.8. Default parameters were used for rest of the options.
Descriptors are the basis of any QSAR modeling strategy and we calculated descriptors using various software packages. Firstly, V-Life MDS 2.0 software was used to calculate 1576 descriptors comprising of topological descriptors, physiological descriptors etc. Secondly, 178 descriptors were calculated using open source Web-Cdk  software based on CDK library. Thirdly, the Dragon  software was used for calculating 1665 descriptors. Additionally, we also used docking energy as descriptors for QSAR modeling. Docking of a compound using AutoDock gives 11 types of energy i.e. free energy, VdW + Hbond + desolv Energy, unbound system energy, moving ligand fixed receptor, Electrostatic Energy, Moving Ligand-Moving Receptor, Final Total Internal Energy, Internal Energy Ligand, Internal Energy Receptor and Torsional Free Energy. These different types of energies were used as descriptors for development of the QSAR based model based on algorithm similar to that of KiDoQ.
Selection of Descriptors
In QSAR modeling, descriptors play an important role and hence selection of highly important descriptors is necessary for building the most efficient QSAR model. To achieve this, we removed descriptors that were invariable and then used the CfsSubsetEval module implemented in the Weka  followed by an F-stepping (leave one out) approach. The CfsubsetEval module along with best fit method finds the best descriptors by considering the predictive ability of each descriptor. While in F-stepping approach, each descriptor is removed from the dataset of n variable, followed by model building and evaluation. If removal of descriptor decreases the performance it will be added in the next step otherwise it is removed finally from the dataset. For example, we calculated 1576 descriptors using v-life software. For example, we calculated 1576 descriptors using v-life software. After removing the invariable descriptors, we selected best descriptors using CfsubsetEval implemented in Weka and obtained 20 descriptors. In final step, F-step approach was implemented in which each descriptor is removed one by one and model performance is measured and this gave us 5 descriptors. This procedure was also implemented on other software's calculated descriptors.
SVM based QSAR models
We used Support Vector Machine (SVM) for prediction of GlmU inhibitors. SVM based on statistical and optimization theory, handles complex structural features. SVMlight software package has been used to develop SVM based QSAR models. This software is freely downloaded from http://www.cs.cornell.edu/People/tj/svm_light/. The performance of models was optimized using systematic variation of different SVM parameters and kernels.
QSAR model using Weka
Weka is a very popular and reliable package widely used in the field of Bioinformatics and Chemoinformatics . It is a collection of machine-learning algorithms and supports several standard features like classification, regression, data preprocessing, and feature selection. Here we used SMOreg (Sequential Minimization Optimization) implemented in Weka to predict inhibitory activity of GlmU compounds. This implementation globally replaces all missing values and transformed nominal attributes into binary ones and also normalizes all attributes.
Multiple linear regression based model
MLR is a statistical technique that finds the linear relationship between two or more independent variables and one dependent variable. In this study, we used the commercial the software STATISTICA  for implementing MLR for developing QSAR model.
Evaluation of QSAR models
Where xi and yi represent actual and predicted pIC 50 value for the ith compound, N is number of compounds, and x represents the averaged value of the actual pIC 50 value for the whole dataset.
Despite this LOOCV strategy, it is very important to use an independent dataset to access overall performance of QSAR model. Thus to evaluate the performance without any bias, we made a random set of 25 compounds as an independent test set and the remaining compounds were used for model development using the LOOCV method. This cycle was repeated about 25 times and predictive r and r2 on training as well as independent sets were observed as shown in Additional file-2.
where SD is the sum of the Squared Deviations between the activities of the test set and mean activities of the training molecules.
Similarity describes how two compounds are structurally similar to each other. Thus if two compounds are highly similar to each other they should have similar chemical as well as biological properties. Using this concept, we tried to find relationship between actual and predicted inhibitory activity values. In order to predict the activity of a compound, we took the average of pIC 50 value for all hits (except self hit) that have high similarity with query compound. We used software JC Search  for searching similar compounds using different similarity cutoff value. A poor correlation among the actual and predicted pIC 50 values was observed, so this was not pursued further.
Target Structure for Docking
In PDB, a number of crystal structures for M. tuberculosis are present but all these structures are found with missing loop in the active site and also in unliganded state. Thus, we modeled only the missing loop portion (G400) of M. Tuberculosis crystal structure using Modeller 9v8. All the inhibitors were docked against the modeled structure of GlmU with the help of AutoDock using a blind docking approach. The docking energies of each inhibitor were computed to develop a QSAR model. These docking energies were used as descriptors and QSAR model for predicting inhibition activity of inhibitors was developed. We achieved poor correlation r = 0.15 between predicted and actual pIC 50 value of inhibitors.
Evaluation and Validation of Docking Protocol
The performance of QSAR models developed based on best descriptors computed using various software and techniques.
Number of Descriptors
Docking Energy Based Descriptor
Correlation values for molecular descriptors with pIC 5 0 value.
Docking based energy descriptors
VdW + Hbond + desolv Energy
Moving Ligand-Moving Receptor
Internal Energy Receptor
Unbound System's Energy
Hybrid QSAR models
The performance of QSAR models developed using descriptors calculated from two or more than two software packages.
Type of Model
Number of Descriptors
V-life + Web-Cdk
V-life + Web-Cdk-Docking
V-life + Web-Cdk-Dragon
Potential GlmU Inhibitors
Screening of Substrate similar Compounds
List of potential GlmU inhibitors selected based on minimum docking free energy
Substrate similar compounds
Free Energy of Binding
Predicted IC50 value
Free Energy of Binding
Predicted IC50 value
Screening of Anti-infective Compounds
We found a list of 3847 anti-infective compounds, out of which 1750 anti-infective compounds satisfy the Lipinski's rule. These compounds were retrieved from PubChem and used for screening against GlmU protein. These compounds were docked in the binding pocket of GlmU and docking energy was computed for each of the molecule. Based on minimum docking energy, we predicted 758 molecules as novel inhibitors of GlmU protein; top 20 compounds having minimum docking free energy is shown in Table 4. We also calculated inhibitory constant of these molecules using V-life descriptors based model.
The virtual screening of chemical compounds library predicts some potential inhibitors. Sometimes false positive prediction by docking or QSAR misleads thereby wasting time and money. Thus, it becomes difficult to identify a compound that is potentially active in experimental study. For example, in our case anti-infective compound PubChem ID 4451056 showed lower free energy as compared to compound PubChem ID 4095801 that is also in agreement with prediction by QSAR model. In such cases a hybrid approach could be beneficial. On this basis, we observed that there was a little difference in free energy of binding between compound 441056 and 4095801 and thus anti-infective compound 441056 could be used for experimental study having higher probability to act as potential inhibitor against GlmU enzyme.
Web Service to Community
One of the major objectives of our group is to bring down the cost of drug discovery. Unfortunately, most of the software for calculating molecular descriptors are commercial and come with number of restrictions. This webserver is a step to promote open source software in computer aided drug discovery. As shown in Table 3, we achieved best performance using model Hybrid 3. Unfortunately, Dragon is a commercial software come with restriction to use for public. Thus in this study, we developed a web server using second best model Hybrid 2, which used V-life, Web-Cdk descriptors and docking energies based descriptors. Though V-life is commercial software but we have license to use it for developing web services. Web-Cdk is based on CDK library which is open source. Server has been developed under Linux environment using CGI-Perl and Python scripts. In this web server, there are three options for molecule submission, 1) Draw structure using JME editor , 2) By pasting molecule in mol/mol2 file format, 3) By file upload using browse option. The result of prediction is seen interactively in the form of bound ligand in GlmU protein and its predicted IC 50 value. We have also shown the descriptors used in this study along with Lipinski rule of five.
The trimeric GlmU protein is considered as a potential target for inhibitor design as it is essential for survival of bacteria. The identification of highly conserved amino acid residues from multiple sequence alignment reveals that single inhibitor may be able to kill wide range of bacterial species. The superimposition of E.coli structure 2OI6 and modeled M. tuberculosis structure shows rmsd of 1.02 A0 using Matchmaker utility of chimera. Docking and QSAR are two well-known approaches in drug designing but each has its own limitation. While identification of lead molecules using QSAR techniques has been widely accepted in the absence of crystal structure of target molecule, docking based method is considered to be more accurate if the target structure is available. Thus we have used both techniques for predicting potential inhibitors.
Recently, a collaborative drug discovery program (CDD)  yielded a collection of potential anti tubercular compounds and predictive models for the same, but our study is focused on identification of potential inhibitors of GlmU using hybrid approach. In this study, a wide range of machine learning techniques has been used to develop QSAR models. It was found that MLR based model performs nearly equal/better as compared to other machine learning techniques. In order to avoid over optimization, it is important to follow (n < 4d) rule where number of descriptors should be less than one fourth of total compounds. All software calculates large number of descriptors, thus there is a need to reduce number of descriptors by removing irrelevant, duplicate and highly correlated descriptors so that we can narrow down to best-performing as well best-representative descriptor set. As shown in Table 2, V-life descriptor chi5chain, Web-Cdk descriptor VCH-4 and Dragon descriptor R1p+, Rtp+ high correlation >0.50 with pIC50 value, which demonstrate the importance of these descriptors. While among docking based descriptors, Moving Ligand-Moving Receptor shows maximum correlation 0.26 with pIC50. The better performance of dragon based selected descriptors may be due to the presence of two descriptors namely R1P+, RTP+ that shows high correlation with inhibitory activity as compared to other that have only one descriptor that shows high correlation. In this study, we integrated both QSAR and docking techniques for predicting inhibition potential of compounds. Using only docking energies as descriptors may give poor correlation because it's not always true that the pose with lowest binding energy is the one with the lowest RMSD and also practically impossible to analyze each docking pose. Besides, there are other kinds of interactions that play important role in predicting binding energies. Thus a hybrid approach may be beneficial to develop better predictive model. As shown in Table 3, hybrid method which combined two or more than two types descriptors. Based on this study, we have screened potential inhibitors against GlmU and predicted 40 compounds as potential inhibitor. By developing BioAssay using recombinant protein, validation of these inhibitors by others will confirm our algorithms and methodology. We hope our web service will serve the community involved in drug discovery as well as it will encourage other scientist working in the field of informatics to develop free software/web-servers.
This study describes the development of a freely available webserver for screening chemical compounds library against GlmU protein. The docking approach also provides valuable information about protein-ligand interaction and help in further ligand based drug designing. This server will be useful to narrow down the time and cost required to screen a chemical library.
List of Abbreviations
Quantitative Structural Activity Relationship
Collaborative Drug Discovery
Multiple Linear Regression
Mean Absolute Error
Coefficient of determinant
Support Vector Machine
Uridine diphosphate N-Acetyl glucosamine-1-phosphate.
We are thankful to Mrs. Arti Garg and Mr. Harinder Singh for providing technical help. The authors are thankful to Open Source for Drug Discovery (OSDD) foundation and Council of Scientific and Industrial Research (CSIR) for financial assistance.
- Robert CG, Kevin VP, Barbara EL: The Evolution of Extensively Drug Resistant Tuberculosis (XDR-TB): History, Status and Issues for Global Control. Infectious Disorders - Drug Targets. 2007, 7 (2): 73:91Google Scholar
- Green E, Obi CL, Nchabeleng M, de Villiers BE, Sein PP, Letsoalo T, Hoosen AA, Bessong PO, Ndip RN: Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen. J Health Popul Nutr. 28 (1): 7-13.
- Cohen ML: Changing patterns of infectious disease. Nature. 2000, 406 (6797): 762-767. 10.1038/35021206.View ArticlePubMedGoogle Scholar
- Livermore DM: Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis. 2003, 36 (Suppl 1): S11-23.View ArticlePubMedGoogle Scholar
- McGowan JE: Economic impact of antimicrobial resistance. Emerg Infect Dis. 2001, 7 (2): 286-292. 10.3201/eid0702.010228.PubMed CentralView ArticlePubMedGoogle Scholar
- Barreteau H, Kovac A, Boniface A, Sova M, Gobec S, Blanot D: Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol Rev. 2008, 32 (2): 168-207. 10.1111/j.1574-6976.2008.00104.x.View ArticlePubMedGoogle Scholar
- Zhang W, Jones VC, Scherman MS, Mahapatra S, Crick D, Bhamidi S, Xin Y, McNeil MR, Ma Y: Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase. Int J Biochem Cell Biol. 2008, 40 (11): 2560-2571. 10.1016/j.biocel.2008.05.003.PubMed CentralView ArticlePubMedGoogle Scholar
- Anurag M, Dash D: Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis. Mol Biosyst. 2009, 5 (12): 1752-1757. 10.1039/b905518p.View ArticlePubMedGoogle Scholar
- Olsen LR, Roderick SL: Structure of the Escherichia coli GlmU pyrophosphorylase and acetyltransferase active sites. Biochemistry. 2001, 40 (7): 1913-1921. 10.1021/bi002503n.View ArticlePubMedGoogle Scholar
- Olsen LR, Vetting MW, Roderick SL: Structure of the E. coli bifunctional GlmU acetyltransferase active site with substrates and products. Protein Sci. 2007, 16 (6): 1230-1235. 10.1110/ps.072779707.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang Z, Bulloch EM, Bunker RD, Baker EN, Squire CJ: Structure and function of GlmU from Mycobacterium tuberculosis. Acta Crystallogr D Biol Crystallogr. 2009, 65 (3): 275-283. 10.1107/S0907444909001036.PubMed CentralView ArticlePubMedGoogle Scholar
- Mochalkin I, Lightle S, Narasimhan L, Bornemeier D, Melnick M, Vanderroest S, McDowell L: Structure of a small-molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site. Protein Sci. 2008, 17 (3): 577-582. 10.1110/ps.073271408.PubMed CentralView ArticlePubMedGoogle Scholar
- Sulzenbacher G, Gal L, Peneff C, Fassy F, Bourne Y: Crystal structure of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase bound to acetyl-coenzyme A reveals a novel active site architecture. J Biol Chem. 2001, 276 (15): 11844-11851. 10.1074/jbc.M011225200.View ArticlePubMedGoogle Scholar
- Kostrewa D, D'Arcy A, Takacs B, Kamber M: Crystal structures of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase, GlmU, in apo form at 2.33 A resolution and in complex with UDP-N-acetylglucosamine and Mg(2+) at 1.96 A resolution. J Mol Biol. 2001, 305 (2): 279-289. 10.1006/jmbi.2000.4296.View ArticlePubMedGoogle Scholar
- Fogel GB, Cheung M, Pittman E, Hecht D: In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase. J Mol Graph Model. 2008, 26 (7): 1145-1152. 10.1016/j.jmgm.2007.10.006.View ArticlePubMedGoogle Scholar
- Saxena AK, Saxena S, Chaudhaery SS: Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors. SAR QSAR Environ Res. 21 (1): 1-20.
- Sun J, Cai S, Mei H, Li J, Yan N, Wang Y: Docking and 3D QSAR study of thiourea analogs as potent inhibitors of influenza virus neuraminidase. J Mol Model. 2010, 16 (12): 1809-1827. 10.1007/s00894-010-0685-9.View ArticlePubMedGoogle Scholar
- Garg A, Tewari R, Raghava GP: KiDoQ: using docking based energy scores to develop ligand based model for predicting antibacterials. BMC Bioinformatics. 2010, 11: 125-10.1186/1471-2105-11-125.PubMed CentralView ArticlePubMedGoogle Scholar
- Ekins S, Bradford J, Dole K, Spektor A, Gregory K, Blondeau D, Hohman M, Bunin BA: A collaborative database and computational models for tuberculosis drug discovery. Mol Biosyst. 2010, 6 (5): 840-851. 10.1039/b917766c.View ArticlePubMedGoogle Scholar
- Wang Y, Bolton E, Dracheva S, Karapetyan K, Shoemaker BA, Suzek TO, Wang J, Xiao J, Zhang J, Bryant SH: An overview of the PubChem BioAssay resource. Nucleic Acids Res. D255-266. 38 Database
- Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH: PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 2009, W623-633. 37 Web ServerPubMed CentralView ArticlePubMedGoogle Scholar
- Morris GMGD, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ: Automated Docking using a lamarkian genetic algorithm and empirical binding free enegy function. J Computational Chemistry. 1998, 19 (14): 1639-1662. 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.View ArticleGoogle Scholar
- Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M: Evaluation of comparative protein modeling by MODELLER. Proteins. 1995, 23 (3): 318-326. 10.1002/prot.340230306.View ArticlePubMedGoogle Scholar
- Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE: UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004, 25 (13): 1605-1612. 10.1002/jcc.20084.View ArticlePubMedGoogle Scholar
- Steinbeck C, Hoppe C, Kuhn S, Floris M, Guha R, Willighagen EL: Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. Curr Pharm Des. 2006, 12 (17): 2111-2120. 10.2174/138161206777585274.View ArticlePubMedGoogle Scholar
- Milano Todeschini: Chemometrics and QSPR Group. [http://michem.disat.unimib.it/]
- Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, H I: The WEKA Data Mining Software: An Update. SIGKDD Explorations. 2009, 11 (1): 10-18. 10.1145/1656274.1656278.View ArticleGoogle Scholar
- STATISTICA (data analysis software system), version 8.0. [http://www.statsoft.com]
- Csizmadia F: JChem: Java Applets and Modules Supporting Chemical Database Handling from Web Browsers. Journal of Chemical Information and Computer Sciences. 2000, 40 (2): 323-324.PubMedGoogle Scholar
- Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, et al.: Clustal W and Clustal X version 2.0. Bioinformatics. 2007, 23 (21): 2947-2948. 10.1093/bioinformatics/btm404.View ArticlePubMedGoogle Scholar
- JAVA MOLECULAR EDITOR. [http://www.molinspiration.com/jme/]